Joseph Oved is an Oncology physician affiliated with Memorial Sloan Kettering Cancer Center. OpenAlex indexes 87 publications with 671 citations (h-index 12); ClinicalTrials.gov lists 2 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Publications indexed by OpenAlex, matched via ORCID. Counts exclude supporting files.
Citations across these publications.
H-index from these publications.
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
- JSP191 Antibody Targeting Conditioning in SCID Patients
Sponsor: Jasper Therapeutics, Inc.
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
8 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Swedish Orphan Biovitrum ABProgram year20251 paymentResearch$150,000openpaymentsdata.cms.gov ↗
- SOBI, INCProgram year202531 payments$29,782openpaymentsdata.cms.gov ↗
- Stryker CorporationProgram year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward. Research funding is listed under each investigator the record names.
NIH funding
2 NIH research awards on record, funded 2023–2026 per NIH RePORTER. The latest:
- Phase 2 Bridging Pre-transplant Inflammatory Dampening for Primary Immune Regulatory Disorders (BRIDGE Trial)
Columbia University Health Sciences
FY2026$647,471R01FD007829 - Phase 2a/2b Study Emapalumab: A Window of Opportunity in Pediatric Aplastic Anemia
Columbia University Health Sciences
FY2025$650,000R01FD008175 - Phase 2a/2b Study Emapalumab: A Window of Opportunity in Pediatric Aplastic Anemia
Sloan-Kettering Inst Can Research
FY2024$650,000R01FD008175
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Hematopoietic Stem Cell Transplant for JAK-STAT Disorders
The Journal of Allergy and Clinical Immunology In Practice
2026 - Primary Immune Regulatory Disorders (PIRD): Tools for Diagnosis and Disease Activity Assessment to Guide Therapy
The Journal of Allergy and Clinical Immunology In Practice
2026 - Improved outcome of HSCT in STAT1 gain-of-function disease following JAK inhibition bridging
Journal of Human Immunity
2025
Similar KOLs
Other experts from the same institution or the same specialty.
Howard Scher, MD
Memorial Sloan Kettering Cancer Center
Robert Motzer, MD
Memorial Sloan Kettering Cancer Center
Charles Sawyers, MD
Memorial Sloan Kettering Cancer Center
Mark Kris, MD
Memorial Sloan Kettering Cancer Center
Carl June, MD
University of Pennsylvania
Rainer Storb
University of Washington
Christina Fitzmaurice, MD
Beth Karlan, MD
University of California, Los Angeles
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”